跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 702 条关于
“AAV5-hRORA”
全部
702
临床试验
121
药物
483
机构
1
资讯
97
去年
Ocugen's OCU410 ArMaDa Trial Proceeds to Phase 2 for Geographic Atrophy
去年
Dry AMD Therapeutic Pipeline Shows Promise with 70+ Companies Advancing Novel Therapies
11个月前
Shape Therapeutics to Present Novel AAV5 Capsid and Alpha-Synuclein Targeting Therapy for Parkinson's Disease at ESGCT Congress
去年
VectorY Therapeutics Secures $1.2B+ Deal for Shape's Brain-Penetrant AAV Capsid Technology
7年前
uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Hemophilia B Patients
去年
EyeDNA's HORA-PDE6b Receives FDA Rare Pediatric Disease Designation for PDE6b Retinitis Pigmentosa
去年
Novel AAV Capsid Variant Shows Superior Gene Delivery to Brain Regions Affected by Huntington's and Parkinson's
5年前
uniQure's Etranacogene Dezaparvovec Shows Sustained Therapeutic Benefit in Hemophilia B Patients
去年
Shape Therapeutics to Present Breakthrough RNA Editing Data for CNS Therapies at ASGCT Annual Meeting
去年
uniQure's AMT-191 Gene Therapy Shows Sustained Enzyme Activity and ERT Discontinuation in Fabry Disease Phase I/IIa Trial
第 1 页,共 10 页
上一页
下一页